Literature DB >> 137674

Na/K- and Mg-ATPase activity in the placenta and in maternal and cord erythrocytes of pre-eclamptic patients.

B R Kuhnert, P M Kuhnert, B A Murray, R J Sokol.   

Abstract

Abnormal sodium balance is known to be associated with pre-eclampsia, but no investigations have been conducted concerning the enzyme which regulates active sodium transport at the cellular level. In this study, the enzyme responsible for active sodium transport--Na/K-ATPase and a nonspecific ATPase Mg-ATPase--were assayed in the placenta and in maternal and fetal (cord) erythrocytes of pregnant women with and without pre-eclampsia. Placental ATPase activity was unaffected by pre-eclampsia. However, in infants of pre-eclamptic mothers, fetal erythrocytes were found to have significantly less activity (42 per cent) of both enzymes than fetal erythrocytes from infants of normal mothers. In pre-eclamptic mothers, erythrocyte Mg-atpase activity was significantly less (41 per cent) than normal and Na/K-ATPase activity was slightly decreased (16 per cent). These results indicate that disruption of active sodium transport in fetal erythrocytes is associated with pre-eclampsia and are not inconsistent with the hypothesis of a circulating "toxin."

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 137674     DOI: 10.1016/0002-9378(77)90314-3

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  3 in total

Review 1.  Fetal endoxins and complications of pregnancy.

Authors:  R C Goodlin; E L Makowski
Journal:  West J Med       Date:  1988-05

2.  Erythrocytic cation transport receptor numbers and activity in pregnancies complicated by essential hypertension and pre-eclampsia.

Authors:  J K Aronson; M P Moore; C W Redman; C Harper
Journal:  Br Med J (Clin Res Ed)       Date:  1984-05-05

3.  Erythrocyte sodium/potassium ATPase activity in severe preeclampsia.

Authors:  C D Adair; G T Haupert; H P Koh; Y Wang; J-C Veille; V Buckalew
Journal:  J Perinatol       Date:  2009-01-22       Impact factor: 2.521

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.